In laboratory evaluations of the test in 280 CSF samples from patients, some with brain or other cancers and some without cancer, Real-CSF correctly identified 67% of 184 cancerous brain lesions and ...

INDIANAPOLIS, June 27, 2023 /PRNewswire/ -- Roche today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys ® Total-Tau CSF assays (tTau) have received U.S. Food and Drug ...

Roche is on a roll: For the second time in less than a year, the company has scored FDA clearance for a pair of assays that can be used together to help spot signs of Alzheimer’s disease. The duo ...

As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...

As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...

Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis ...

A research group has investigated how Alzheimer's disease can be diagnosed more reliably in the future. A research group at LMU University Hospital has investigated how Alzheimer's disease can be ...

This article was produced in partnership with the Davos Alzheimer’s Collaborative by Scientific American Custom Media, a division separate from the magazine’s board of editors. Henry, a carpenter in ...